Optimization of antimicrobial stewardship programs using therapeutic drug monitoring and pharmacokinetics–pharmacodynamics protocols: a cost-benefit review

JP Telles, R Morales Jr, CH Yamada… - Therapeutic Drug …, 2023 - journals.lww.com
Purpose: Antimicrobial stewardship programs are important for reducing antimicrobial
resistance because they can readjust antibiotic prescriptions to local guidelines, switch …

Optimizing the use of beta-lactam antibiotics in clinical practice: a test of time

A Tilanus, G Drusano - Open Forum Infectious Diseases, 2023 - academic.oup.com
Despite their limitations, the pharmacokinetics (PK) and pharmacodynamics (PD) indices
form the basis for our current understanding regarding antibiotic development, selection …

Combination of pharmacokinetic and pathogen susceptibility information to optimize meropenem treatment of gram-negative infections in critically Ill patients

U Liebchen, F Weinelt, C Scharf… - Antimicrobial Agents …, 2022 - Am Soc Microbiol
Meropenem is one of the most frequently used antibiotics to treat life-threatening infections
in critically ill patients. This study aimed to develop a meropenem dosing algorithm for the …

[HTML][HTML] Pharmacokinetics of meropenem in critically ill patients in Saudi Arabia

A Alsultan, SA Dasuqi, F Aljamaan, RA Omran… - Saudi Pharmaceutical …, 2021 - Elsevier
Background Meropenem is commonly used in the ICU to treat gram-negative infections. Due
to various pathophysiological changes, critically ill patients are at higher risk of having …

Does Two-Step Infusion Improve the Pharmacokinetics/Pharmacodynamics Target Attainment of Meropenem in Critically Ill Patients?

J Chen, Q Wang, S Li, R Han, C Wang, S Cheng… - Journal of …, 2024 - Elsevier
The optimal method for administering meropenem remains controversial. This study was
conducted to explore the optimal two-step infusion strategy (TIT), and to investigate whether …

A descriptive pharmacokinetic/pharmacodynamic analysis of ceftazidime‐avibactam in a case series of critically ill patients with augmented renal clearance

Y Xu, J Tang, B Yuan, X Luo, P Liang… - Pharmacology …, 2024 - Wiley Online Library
To describe the pharmacokinetics/pharmacodynamics (PK/PD) of a 2 h infusion of
ceftazidime‐avibactam (CAZ‐AVI) in critically ill patients with augmented renal clearance …

[PDF][PDF] 头孢他啶-阿维巴坦的PK/PD 靶值达标情况及治疗药物监测研究进展

于佳鑫, 左玮, 杨阳, 林子溦, 张波 - 中国药学杂志, 2023 - journal11.magtechjournal.com
多重耐药革兰阴性菌感染的危重症患者, 因个体间药动学(PK) 参数差异较大,
接受说明书推荐给药剂量的3 内酰胺类抗菌药物治疗, 其药动学/药效学(pharmacodynamics …

Dose optimization of meropenem for critically ill patients by pharmacokinetic/pharmacodynamic simulation

NT Cuc, NH Anh, NTN Tien, NDM Vuong… - Tạp chí Nghiên cứu …, 2023 - jprdi.vn
Meropenem is a broad-spectrum carbapenem antibiotic which is commonly prescribed for
treatment of severe infections caused by multidrug-resistant bacteria [1]. In critically ill …

[PDF][PDF] Dose optimization of meropenem for critically ill patients by pharmacokinetic/pharmacodynamic simulation

NTC Le Dinh Vana, NH Anh Jr, NTN Tiena, N Dang - canhgiacduoc.org.vn
Meropenem is a broad-spectrum carbapenem antibiotic which is commonly prescribed for
treatment of severe infections caused by multidrug-resistant bacteria [1]. In critically ill …